Table 8.
Top ten most-cited documents in leishmaniasis research on NPs.
| No. | Document (Authors/Year/Journal) | DOI | Year | GC | C/Y | LC | LC/GC Ratio (%) |
|---|---|---|---|---|---|---|---|
| 1 | Müller RH, 2001, Adv Drug Deliv Rev | 10.1016/S0169-409X(00)00118-6 | 2001 | 1223 | 53.17 | 12 | 0.98 |
| 2 | Schairer DO, 2012, Virulence | 10.4161/viru.20328 | 2012 | 337 | 28.08 | 2 | 0.59 |
| 3 | Matea CT, 2017, Int J Nanomed | 10.2147/IJN.S138624 | 2017 | 326 | 46.57 | 1 | 0.31 |
| 4 | Allahverdiyev AM, 2011, Future Microbiol | 10.2217/fmb.11.78 | 2011 | 279 | 21.46 | 14 | 5.02 |
| 5 | Tiuman TS, 2011, Int J Infect Dis | 10.1016/j.ijid.2011.03.021 | 2011 | 245 | 18.85 | 18 | 7.35 |
| 6 | Kayser O, 2003, Int J Pharm | 10.1016/S0378-5173(02)00686-5 | 2003 | 181 | 8.62 | 11 | 6.08 |
| 7 | Allahverdiyev AM, 2011, Int J Nanomedicine | 10.2147/ijn.s23883 | 2011 | 164 | 12.62 | 55 | 33.54 |
| 8 | Van De Ven H, 2012, J Control Release | 10.1016/j.jconrel.2012.05.037 | 2012 | 124 | 10.33 | 17 | 13.71 |
| 9 | Khalil AT, 2018, Artif Cells Nanomed Biotechnol | 10.1080/21691401.2017.1345928 | 2018 | 118 | 19.67 | 8 | 6.78 |
| 10 | Savoia D, 2015, J Infect Dev Ctries | 10.3855/jidc.6833 | 2015 | 117 | 13.00 | 3 | 2.56 |